GERD (acid reflux) Board decisions

The Board denied the veteran's claims for increased ratings for various service-connected conditions, finding that the evidence did not support a higher rating under applicable criteria.

The Board denied the veteran's claim for a rating in excess of 10 percent for gastroesophageal reflux disease (GERD) as the evidence did not show considerable impairment of health.

The appeal for entitlement to service connection for GERD is dismissed as the Board granted service connection for this condition in a separately pending appeal.

The Board denied an earlier effective date for the award of service connection for GERD, as there was no evidence that a claim for this condition was filed prior to June 21, 2018.

The Board granted a 60 percent rating for the Veteran's GERD, finding that his symptoms more nearly approximated those required for such a rating.

The Board denied the Veteran's appeal for an initial disability rating in excess of 10 percent for his service-connected gastroesophageal reflux disease (GERD) as the evidence did not support a higher rating.

The Board denied the applications to revise a March 2021 rating decision based on clear and unmistakable error (CUE) for various claims of service connection, finding no evidence that the correct facts were not before the RO or that the applicable statutory and regulatory provisions were incorrectly applied.

The Board granted service connection for gastroesophageal reflux disease (GERD) and neurogenic bladder, both as secondary to the Veteran's service-connected lumbosacral strain with degenerative arthritis.

The Board remands the claims for service connection for GERD, right hand skin disorder, and left hand skin disorder for further development of medical evidence.

The Board denied an initial evaluation in excess of 30 percent for the Veteran's service-connected gastroesophageal reflux disease (GERD) as the evidence did not show symptoms productive of considerable or severe impairment of health.

The Board denied increased ratings for tension headaches, GERD, lumbosacral strain, erectile dysfunction, and bilateral pes planus, but granted a separate rating of 10 percent for bilateral plantar fasciitis. The appeal was remanded to provide an adequate examination for the right ankle sprain.

The Board granted an initial disability evaluation of 60 percent for gastroesophageal reflux disease (GERD) based on the severity of symptoms reported and observed, which are considered to be productive of severe impairment of health.

The Board granted an earlier effective date of April 5, 2022, for a 60 percent evaluation of GERD with hernia hiatal and IBS.

The Board granted service connection for gastroesophageal reflux disease (GERD) based on the Veteran's combat experience and credible lay statements regarding the onset, continuity, and medical management of symptoms during and since active service.

The Board denied service connection for chronic bronchitis, chronic sinusitis, irritable bowel syndrome (IBS), bowel inconsistency, restrictive food intake disorder, a bilateral ankle condition, a neck disorder, and a heart disorder as the evidence does not reflect that the Veteran has a current diagnosis of these disorders. The claim for PTSD due to military sexual trauma was denied based on the lack of a current diagnosis.

The Board remands the case to obtain a more accurate assessment of the Veteran's IBS disability without considering the ameliorative effects of medication.

The Board denied an evaluation in excess of 60 percent for scleroderma, an evaluation in excess of 40 percent for fibromyalgia, but granted a 30 percent rating for GERD.

The Board denied an earlier effective date for the grant of service connection for anxiety and depressive disorders, but granted a more favorable effective date for right lower extremity radiculopathy of the sciatic nerve.

The Board granted an initial 30 percent rating for the Veteran's gastroesophageal reflux disease (GERD) based on symptoms including persistently recurrent epigastric distress, pyrosis, regurgitation, substernal pain, nausea, vomiting, and sleep disturbance.

The Board granted service connection for major depressive disorder (MDD) and remanded claims related to eye conditions, traumatic brain injury (TBI), temporomandibular joint dysfunction (TMJ), and tension headaches.